23-Chem-B2 Environmental Engineering · December 2019
Nivaar worked solution (AI-drafted; not reviewed by a licensed engineer)
National Exam 16-Chem-B2, Environmental Engineering — December 2019. 3 hours, Closed-Book Exam with a candidate-prepared 8½×11" double-sided aid sheet. Any five (5) of the seven questions constitute a complete paper (100 marks); all seven are solved below for completeness.
Reference texts: Metcalf & Eddy (Tchobanoglous, Burton, Stensel), Wastewater Engineering: Treatment and Reuse, 4th ed.; Davis & Cornwell, Introduction to Environmental Engineering, 5th ed.; Turner, Workbook of Atmospheric Dispersion Estimates, 2nd ed.; Cooper & Alley, Air Pollution Control: A Design Approach, 4th ed.
Question text not reproduced: the examination questions are © Engineers and Geoscientists BC. Open the official past paper (linked at the top of this page) to read the question, then follow the worked solution below.
For a site with residual petroleum hydrocarbon contamination in the vadose or saturated zone, in- situ chemical oxidation (ISCO) is an appropriate technology: a strong oxidant (commonly modified Fenton's reagent, sodium/potassium permanganate, or activated persulfate) is injected through a network of wells directly into the contaminated soil/groundwater, chemically oxidizing the hydrocarbons in place to CO₂, water and simpler, more biodegradable intermediates without excavation.
Delivery is engineered around achieving adequate oxidant contact with the contaminant mass (injection well spacing and pressure sized to the site's hydraulic conductivity and radius of influence), and the oxidant dose is set from the site's total oxidant demand (natural organic matter and reduced minerals in the soil consume oxidant before it ever reaches the target hydrocarbons, so a pilot-scale oxidant-demand test is normally run first to avoid under-dosing).
Bioventing is an in-situ technique in which air (and sometimes nutrients) is injected into the unsaturated (vadose) soil zone at a low flow rate, just sufficient to sustain aerobic conditions for the indigenous hydrocarbon- or solvent-degrading microbial population, without volatilizing and stripping the contaminant the way soil vapour extraction does. Because the objective is biodegradation rather than volatilization, injection/extraction rates are kept low, and performance is tracked by monitoring in-situ CO₂ generation and O₂ consumption rates (an oxygen-uptake test) rather than off-gas contaminant concentration.
| Element | What it means | Why it protects human health |
|---|---|---|
| Accuracy (calibration/traceability) | The instrument reading matches the true concentration, verified by calibration against certified reference standards traceable to a national metrology body. | A biased (inaccurate) instrument can under-report a real exceedance, letting a health-protective standard be silently violated without triggering a compliance response. |
| Precision (repeatability) | Repeated measurements of the same sample cluster tightly together, quantified by the method's standard deviation/coefficient of variation. | Poor precision widens the uncertainty band around a compliance decision, so a result close to the standard cannot be confidently judged as compliant or non-compliant without a defensible confidence interval. |
| Representativeness / detection limit | The sample and analytical method's detection limit are appropriate to the pollutant and the standard being checked (e.g. a method detection limit well below the health-based limit, and a sampling location/frequency that represents actual exposure). | A method that cannot reliably detect the pollutant below the health-based limit, or a sample that is not representative of what people actually breathe or drink, gives a false sense of compliance even when accuracy and precision are individually fine. |
All three elements are necessary together: an accurate but imprecise method cannot support a defensible pass/fail decision near the standard, and even an accurate, precise method is useless if its detection limit sits above the health-based limit it is meant to verify — regulatory compliance monitoring programs are therefore designed (and audited) against all three simultaneously, not any one in isolation.
